Brief: Carisma Unveils Pre-Clinical Data On Anti-GPC3 In Vivo CAR-M Therapy For Hepatocellular Carcinoma

Carisma Therapeutics

08/11/2024 12:39

Nov 8 (Reuters) - Carisma Therapeutics Inc  CARM.O :
    * CARISMA UNVEILS PROMISING PRE-CLINICAL DATA ON ANTI-GPC3
IN VIVO
CAR-M THERAPY FOR HEPATOCELLULAR CARCINOMA
    * CARISMA -ANTI-GPC3 IN VIVO CAR-M THERAPY WELL TOLERATED IN
MOUSE
MODELS, HIGHLIGHTING ITS POTENTIAL AS AN OFF--SHELF TREATMENT
FOR GPC3+ SOLID TUMORS

Source text:  ID:nPnc4mVPsa 
Further company coverage:  CARM.O 

 (Reuters.Briefs@thomsonreuters.com)